Rule 8.3 - Tepnel Life Sciences PLC
July 19 2005 - 2:22PM
UK Regulatory
Bio-Rad Laboratories, Inc.
FORM 8.3
DEALINGS BY PERSONS WHO OWN OR CONTROL 1% OR MORE OF ANY CLASS OF RELEVANT
SECURITY
(Rule 8.3 of The City Code on Takeovers and Mergers)
Name of purchaser/vendor * Bio-Rad Laboratories, Inc.
------------------------------------------- --------------------------
Company dealt in Tepnel Life Sciences PLC
------------------------------------------- --------------------------
Relevant security dealt in Ordinary shares
------------------------------------------- --------------------------
If a connected EFM, name of offeree/offeror
with which connected
------------------------------------------- --------------------------
If a connected EFM, nature of connection #
------------------------------------------- --------------------------
Date of dealing 18 July, 2005
------------------------------------------- --------------------------
DEALINGS (a)
Amount bought Price per unit (currency
must be stated)
------------------------------------------- --------------------------
------------------------------------------- --------------------------
Amount sold Price per unit (currency
must be stated)
------------------------------------------- --------------------------
250,000 10.00 pence/share
------------------------------------------- --------------------------
Resultant total amount and percentage of 5,380,000 ordinary shares
the same relevant security owned or (2.53% of the outstanding
controlled ordinary shares)
------------------------------------------- --------------------------
IS A SUPPLEMENTAL FORM 8 (DERIVATIVE)/FORM 8 (OPTION) ATTACHED? NO
Date of disclosure 19 July, 2005
------------------------------------------- --------------------------
Contact name Tom Brida
------------------------------------------- --------------------------
Telephone number (510) 741-6345
------------------------------------------- --------------------------
* Specify the owner or controller in addition to the person dealing. The naming
of nominees or vehicle companies is insufficient. In the case of disclosure of
dealings by fund managers on behalf of discretionary clients, the clients need
not be named.
# See the definition of "connected fund managers and principal traders" in the
Definitions Section of the Code.
(a) If disclosing dealings/holdings in derivatives or options, please attach
Supplemental Form 8 (Derivative) or Supplemental Form 8 (Option), as
appropriate.
For details of the Code's dealing disclosure requirements, see Rule 8 and its
Notes which can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk.
Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024